Comment on Will Pharma Companies Get Out of Alzheimer's Disease R&D?

Will Pharma Companies Get Out of Alzheimer's Disease R&D?

Clinical trial results in Alzheimer’s Disease (AD) reported over the past few weeks have been disappointing to both patients and the academic community.  The failure of both bapineuzumab (Pfizer/Johnson & Johnson) and solanezumab (Eli Lilly) to improve cognitive function has shown the difficulties inherent in trying to develop drugs to [...]

 

Comment On This Story

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News